ASN-001

ASN-001 is an orally active CYP-17A1 lyase inhibitor that selectively inhibits testosterone synthesis. ASN-001 has anticancer activity and can be used for research in the field of prostate cancer[1].

Product Specifications

CAS Number

[1429329-63-4]

UNSPSC

12352005

Target

Cytochrome P450

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/asn-001.html

Smiles

FC1=CC=C(C2=NC=C(C(C3=CC=NC=C3)(C)O)S2)C=C1

Molecular Formula

C16H13FN2OS

Molecular Weight

300.35

References & Citations

[1]Barata P, et al. Treatment selection for men with metastatic prostate cancer who progress on upfront chemo-hormonal therapy. Prostate. 2018 Sep;78 (13) :1035-1041.